Earn a $50 gift card*
If you refer or sign up your company you'll get a $50 gift card*
Refer your company by clicking below or by emailing us the details on bookings@flufighters.com.au
Requesting a quote is easy and fast! All you need to do is click the button below and fill out your details. One of our friendly staff will get in contact shortly.
*Minimum employee uptake of 10 people
Workplace Flu Vaccinations for 2025
Workplace flu vaccinations are a great way to protect your team. Flu Fighters offer onsite flu vaccinations for businesses across Greater Sydney and can create a tailored solution to prepare your business for a healthy year.
Influenza in 2025
Influenza, also known as the “flu”, can have a powerful effect on an organisation and their workers’ health due to causing high rates of absenteeism and lower rates of productivity annually. That is why it is important to start planning early, so that you can protect your workplace from the flu.
The effect of the flu on your business
Each year, the flu costs Australian businesses more than $2 billion, with an estimated 1,500,000 workdays lost each year due to the illness. Unlike a cold, the flu can last for a week or more, and individuals can feel fatigue for a period of two to three weeks.
The influenza virus is also highly contagious, with the infection transferring from person to person before noticeable symptoms are present. Therefore, prevention through an annual onsite vaccination program can be the key to keeping your workforce healthy.
We do more than just the flu!
Most commonly we bundle influenza vaccination with COVID vaccination for your team members who opt in. We also offer a range of vaccinations including travel vaccines and workplace exposure vaccines. Contact us today and we can tailor a package for you.
Frequently Asked Questions
Yes! We offer a range of vaccinations including COVID-19, travel vaccines and workplace exposure vaccines. Contact us today and we can tailor a package for you.
Influenza, commonly called “the flu”, is a contagious disease caused by a virus that spreads easily from person to person. Compared with many other viral respiratory infections such as the common cold, influenza infection can cause severe illness and can also precipitate serious and life-threatening complications. Influenza viruses infect many parts of the body, including the nose, throat and lungs. Influenza symptoms include fever, cough, sore throat, fatigue, muscle aches, headaches, runny nose and watery eyes. Although the fever and body ache usually last for 3 – 5 days, coughing and fatigue can persist for two weeks or more.
Yes, the flu shot is still recommended in 2025. The Australian Government recommends that everyone over the age of 6 months has a flu vaccination every year. It’s difficult to predict who will catch the flu or who will become seriously ill from it. The flu can require hospitalisation and can even be fatal.
Getting vaccinated against the flu helps protect both you and the people around you. It’s particularly important to protect vulnerable people in the community who can’t be vaccinated, such as babies who are younger than 6 months and adults with low immunity.
There are two main reasons for getting a yearly flu vaccine:
-
Flu viruses are frequently changing and vaccines are updated each season to protect against the most recent and common circulating strains.
-
A person’s immune protection from influenza vaccination declines over time and annual vaccination is recommended.
Common side effects following seasonal flu vaccination include soreness, fever, redness, pain and swelling at the injection site, vomiting and malaise. These side effects are usually mild and resolve within a few days. Allergic reactions usually occur very soon after vaccination so it is important to wait in the allocated area for 15 minutes after being vaccinated.
The Australian Influenza Vaccine Committee (AIVC) has released its recommendations for the composition of the flu vaccine for Australia in 2025, which aligns with the recommendations from the World Health Organisation.
The AIVC recommends the following viruses for the 2025 southern hemisphere season quadrivalent influenza vaccines:
For egg-based quadrivalent influenza vaccines:
-
an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
-
an A/Croatia/10136RV/2023 (H3N2)-like virus; and
-
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
For cell- or recombinant-based quadrivalent influenza vaccines:
-
an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
-
an A//District of Columbia/27/2023 (H3N2)-like virus; and
-
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
The recommendation for the B/Yamagata lineage component of quadrivalent influenza vaccines remains unchanged from previous recommendations:
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The AIVC recommendation for the composition of influenza vaccines for Australia in 2025 differs from the 2024 southern hemisphere and 2024/25 northern hemisphere recommendations. The southern hemisphere 2025 vaccine will contain one new strain for the Influenza A(H3N2) subtype virus component.